1 like0 reposts0 replies
AACR Annual Meeting 2026
April 17–22, 2026 · San Diego · 2418 items
Over 22,000 attendees and more than 7,400 abstracts, including a record 265 clinical trial abstracts. This section collects on-site analysis across fifteen signal directions, plus late-breaking, clinical-trial and new-drug abstracts.
Rahul Banerjee, MD, FACP@RahulBanerjeeMD National Cancer Institute@theNCI 6 likes4 reposts0 repliesGiovanni Nigita, PhD@GianniNigita Want to learn more about our institution? Stop by our booth (#4307) at #AACR26
3 likes1 repost0 repliesMoffitt Cancer Center@MoffittNews 0 likes0 reposts0 repliesLiz Highleyman@LizHighleyman 0 likes0 reposts0 repliesEmil Lou, MD, PhD, FACP, FASCO@cancerassassin1 We published this in 2019 in a wonderful collaboration with the
3 likes1 repost0 repliesEmil Lou, MD, PhD, FACP, FASCO@cancerassassin1 LUNGevity Foundation@LUNGevity 1 like1 repost0 repliesMemorial Sloan Kettering Cancer Center@MSKCancerCenter Moffitt Cancer Center@MoffittNews From the Moffitt booth at #AACR26, Moffitt’s Susan Vadaparampil, PhD, MPH (
15 likes3 reposts0 repliesTakaraBioUSA@TakaraBioUSA 0 likes0 reposts0 repliesMoffitt Cancer Center@MoffittNews Cancer Immunology Research@CIR_AACR 0 likes0 reposts0 repliesUC San Diego Health Moores Cancer Center@UCSDCancer 0 likes0 reposts0 repliesBlood Cancer Discovery@BCD_AACR 0 likes0 reposts0 repliesaacr.org Are Clinical Trials Becoming Increasingly Consolidated in Large Cities?
A LUNGevity study found U.S. phase I NSCLC trial sites fell 44% between 2020 and 2024, with trials concentrating at the highest-volume centres.
No engagement yetUC San Diego Health Moores Cancer Center@UCSDCancer 2 likes1 repost0 repliesUT MD Anderson@UTMDAnderson 12 likes4 reposts0 repliesMoffitt Cancer Center@MoffittNews Moffitt's Ahmad Tarhini, MD, PhD
AACR@AACR New Drugs on the Horizon, Part 3:
2 likes3 reposts0 repliesDr. Patrick Hwu@PatrickHwuMD Great presentation from Ignacio Melero (
8 likes5 reposts2 repliesMoffitt Cancer Center@MoffittNews 3 likes1 repost1 replyMBC Advocate@MBCadvocate Best news ever! AVA6103 includes ER+ metastatic breast cancer! A major step forward!
Clinical Cancer Research@CCR_AACR 2 likes0 reposts0 repliesSiteman Cancer Center@SitemanCenter 4 likes2 reposts0 repliesYale Cancer Center@YaleCancer Young Kwang Chae, MD, MPH, MBA@youngkwangchae Fascinating deep dive into the "Epigenetic histories of blood" from Dr.
0 likes0 reposts0 repliesUChicagoCancerCenter@UCCancerCenter 0 likes0 reposts0 repliesMoffitt Cancer Center@MoffittNews 0 likes0 reposts0 repliesClinical Cancer Research@CCR_AACR 0 likes0 reposts0 replies